Abstract
To review results of vitreous surgery for branch and central retinal vein occlusion (BRVO and CRVO). All cases of vitrectomy with multiple transvenous chorioretinotomies for retinal vein occlusion at a vitreoretinal subspecialty practice were reviewed. Twenty eyes of 20 patients (four with BRVO and 16 with CRVO) were included. Mean time from diagnosis to surgery was 15 months, and mean postoperative follow-up was 22 months. Injections of bevacizumab or ranibizumab decreased postoperatively (P < .0001; Poisson regression model), while log-MAR visual acuity improved (P = .0396; Wilcoxon signed-rank test). Ten eyes required no further injections postoperatively, and three eyes required one postoperative injection. Macular edema expressed as OCT maximum macular thickness was significantly reduced postoperatively at 6 months and 12 months (P = .0077 and .0093, respectively). In a pilot study of retinal vein occlusion treatment, multiple transvenous chorioretinotomy surgery significantly improved visual acuity and macular edema and reduced intravitreal drug dependency. Further study is warranted.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
